Jessica Hitchcock

Publications (6)30.89 Total impact

• Article: Systemic Flagellin Immunization Stimulates Mucosal CD103+ Dendritic Cells and Drives Foxp3+ Regulatory T Cell and IgA Responses in the Mesenteric Lymph Node.

  Adriana Flores-Langarica, Jennifer L Marshall, Jessica Hitchcock, Charlotte Cook, Jonathan Jobanputra, Saeeda Bobat, Ewan A Ross, Ruth E Coughlan, Ian R Henderson, Satoshi Uematsu, Shizuo Akira, Adam F Cunningham
  [show abstract] [hide abstract]
  ABSTRACT: Mucosal immunity is poorly activated after systemic immunization with protein Ags. Nevertheless, induction of mucosal immunity in such a manner would be an attractive and simple way to overcome the intrinsic difficulties in delivering Ag to such sites. Flagellin from Salmonella enterica serovar Typhimurium (FliC) can impact markedly on host immunity, in part via its recognition by TLR5. In this study, we show that systemic immunization with soluble FliC (sFliC) drives distinct immune responses concurrently in the mesenteric lymph nodes (MLN) and the spleen after i.p. and s.c. immunization. In the MLN, but not the spleen, sFliC drives a TLR5-dependent recruitment of CD103(+) dendritic cells (DCs), which correlates with a diminution in CD103(+) DC numbers in the lamina propria. In the MLN, CD103(+) DCs carry Ag and are the major primers of endogenous and transgenic T cell priming. A key consequence of these interactions with CD103(+) DCs in the MLN is an increase in local regulatory T cell differentiation. In parallel, systemic sFliC immunization results in a pronounced switching of FliC-specific B cells to IgA in the MLN but not elsewhere. Loss of TLR5 has more impact on MLN than splenic Ab responses, reflected in an ablation of IgA, but not IgG, serum Ab titers. Therefore, systemic sFliC immunization targets CD103(+) DCs and drives distinct mucosal T and B cell responses. This offers a potential "Trojan horse" approach to modulate mucosal immunity by systemically immunizing with sFliC.
  The Journal of Immunology 11/2012; · 5.79 Impact Factor
• Article: Thymic Function Is Maintained during Salmonella-Induced Atrophy and Recovery.

  Ewan A Ross, Ruth E Coughlan, Adriana Flores-Langarica, Sian Lax, Julia Nicholson, Guillaume E Desanti, Jennifer L Marshall, Saeeda Bobat, Jessica Hitchcock, Andrea White, William E Jenkinson, Mahmood Khan, Ian R Henderson, Gareth G Lavery, Christopher D Buckley, Graham Anderson, Adam F Cunningham
  [show abstract] [hide abstract]
  ABSTRACT: Thymic atrophy is a frequent consequence of infection with bacteria, viruses, and parasites and is considered a common virulence trait between pathogens. Multiple reasons have been proposed to explain this atrophy, including premature egress of immature thymocytes, increased apoptosis, or thymic shutdown to prevent tolerance to the pathogen from developing. The severe loss in thymic cell number can reflect an equally dramatic reduction in thymic output, potentially reducing peripheral T cell numbers. In this study, we examine the relationship between systemic Salmonella infection and thymic function. During infection, naive T cell numbers in peripheral lymphoid organs increase. Nevertheless, this occurs despite a pronounced thymic atrophy caused by viable bacteria, with a peak 50-fold reduction in thymocyte numbers. Thymic atrophy is not dependent upon homeostatic feedback from peripheral T cells or on regulation of endogenous glucocorticoids, as demonstrated by infection of genetically altered mice. Once bacterial numbers fall, thymocyte numbers recover, and this is associated with increases in the proportion and proliferation of early thymic progenitors. During atrophy, thymic T cell maturation is maintained, and single-joint TCR rearrangement excision circle analysis reveals there is only a modest fall in recent CD4(+) thymic emigrants in secondary lymphoid tissues. Thus, thymic atrophy does not necessarily result in a matching dysfunctional T cell output, and thymic homeostasis can constantly adjust to systemic infection to ensure that naive T cell output is maintained.
  The Journal of Immunology 09/2012; 189(9):4266-74. · 5.79 Impact Factor
• Article: CD31 is required on CD4+ T cells to promote T cell survival during Salmonella infection.

  Ewan A Ross, Ruth E Coughlan, Adriana Flores-Langarica, Saeeda Bobat, Jennifer L Marshall, Khiyam Hussain, James Charlesworth, Nikita Abhyankar, Jessica Hitchcock, Cristina Gil, Constantino López-Macías, Ian R Henderson, Mahmood Khan, Steve P Watson, Ian C M MacLennan, Christopher D Buckley, Adam F Cunningham
  [show abstract] [hide abstract]
  ABSTRACT: Hematopoietic cells constitutively express CD31/PECAM1, a signaling adhesion receptor associated with controlling responses to inflammatory stimuli. Although expressed on CD4(+) T cells, its function on these cells is unclear. To address this, we have used a model of systemic Salmonella infection that induces high levels of T cell activation and depends on CD4(+) T cells for resolution. Infection of CD31-deficient (CD31KO) mice demonstrates that these mice fail to control infection effectively. During infection, CD31KO mice have diminished numbers of total CD4(+) T cells and IFN-γ-secreting Th1 cells. This is despite a higher proportion of CD31KO CD4(+) T cells exhibiting an activated phenotype and an undiminished capacity to prime normally and polarize to Th1. Reduced numbers of T cells reflected the increased propensity of naive and activated CD31KO T cells to undergo apoptosis postinfection compared with wild-type T cells. Using adoptive transfer experiments, we show that loss of CD31 on CD4(+) T cells alone is sufficient to account for the defective CD31KO T cell accumulation. These data are consistent with CD31 helping to control T cell activation, because in its absence, T cells have a greater propensity to become activated, resulting in increased susceptibility to become apoptotic. The impact of CD31 loss on T cell homeostasis becomes most pronounced during severe, inflammatory, and immunological stresses such as those caused by systemic Salmonella infection. This identifies a novel role for CD31 in regulating CD4 T cell homeostasis.
  The Journal of Immunology 08/2011; 187(4):1553-65. · 5.79 Impact Factor
• Article: T-zone localized monocyte-derived dendritic cells promote Th1 priming to Salmonella.

  Adriana Flores-Langarica, Jennifer L Marshall, Saeeda Bobat, Elodie Mohr, Jessica Hitchcock, Ewan A Ross, Ruth E Coughlan, Mahmood Khan, Nico Van Rooijen, Ian R Henderson, Ian C M Maclennan, Adam F Cunningham
  [show abstract] [hide abstract]
  ABSTRACT: Control of intracellular Salmonella infection requires Th1 priming and IFN-γ production. Here, we show that efficient Th1 priming after Salmonella infection requires CD11c(+) CD11b(hi) F4/80(+) monocyte-derived dendritic cells (moDCs). In non-infected spleens, moDCs are absent from T-cell zones (T zones) of secondary lymphoid tissues, but by 24 h post-infection moDCs are readily discernible in these sites. The accumulation of moDCs is more dependent upon bacterial viability than bacterial virulence. Kinetic studies showed that moDCs were necessary to prime but not sustain Th1 responses, while ex vivo studies showed that antigen-experienced moDCs were sufficient to induce T-cell proliferation and IFN-γ production via a TNF-α-dependent mechanism. Importantly, moDCs and cDCs when co-cultured induced superior Th1 differentiation than either subset alone, and this activity was independent of TNF-α. Thus, optimal Th1 development to Salmonella requires the rapid accumulation of moDCs within T zones and their collaboration with cDCs.
  European Journal of Immunology 06/2011; 41(9):2654-65. · 5.10 Impact Factor
• Article: Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection.

  Saeeda Bobat, Adriana Flores-Langarica, Jessica Hitchcock, Jennifer L Marshall, Robert A Kingsley, Margaret Goodall, Cristina Gil-Cruz, Karine Serre, Denisse L Leyton, Shirdi E Letran, Fabrina Gaspal, Rebecca Chester, Jayne L Chamberlain, Gordon Dougan, Constantino López-Macías, Ian R Henderson, James Alexander, Ian C M MacLennan, Adam F Cunningham
  [show abstract] [hide abstract]
  ABSTRACT: Clearance of disseminated Salmonella infection requires bacterial-specific Th1 cells and IFN-γ production, and Th1-promoting vaccines are likely to help control these infections. Consequently, vaccine design has focused on developing Th1-polarizing adjuvants or Ag that naturally induce Th1 responses. In this study, we show that, in mice, immunization with soluble, recombinant FliC protein flagellin (sFliC) induces Th2 responses as evidenced by Ag-specific GATA-3, IL-4 mRNA, and protein induction in CD62L(lo) CD4(+) T cells without associated IFN-γ production. Despite these Th2 features, sFliC immunization can enhance the development of protective Th1 immunity during subsequent Salmonella infection in an Ab-independent, T-cell-dependent manner. Salmonella infection in sFliC-immunized mice resulted in augmented Th1 responses, with greater bacterial clearance and increased numbers of IFN-γ-producing CD4(+) T cells, despite the early induction of Th2 features to sFliC. The augmented Th1 immunity after sFliC immunization was regulated by T-bet although T-bet is dispensable for primary responses to sFliC. These findings show that there can be flexibility in T-cell responses to some subunit vaccines. These vaccines may induce Th2-type immunity during primary immunization yet promote Th1-dependent responses during later infection. This suggests that designing Th1-inducing subunit vaccines may not always be necessary since this can occur naturally during subsequent infection.
  European Journal of Immunology 03/2011; 41(6):1606-18. · 5.10 Impact Factor
• Article: Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant.

  Ann L White, Alison L Tutt, Sonya James, Kevin A Wilkinson, Fernanda V V Castro, Sandra V Dixon, Jessica Hitchcock, Mahmood Khan, Aymen Al-Shamkhani, Adam F Cunningham, Martin J Glennie
  [show abstract] [hide abstract]
  ABSTRACT: In this study, we investigated the mouse dendritic cell (DC) receptor, complement receptor 4 (CR4; CD11c/CD18), as an immunotarget for triggering humoral immunity. Comparison of antibody titres generated against a panel of 13 anti-antigen-presenting cell receptor monoclonal antibodies, with or without conjugated ovalbumin (OVA), revealed uniquely rapid and robust responses following CR4 targeting, with antibody titres approaching 1 : 100 000 7 days after a single dose of antigen. Furthermore, using just 100 ng OVA conjugated to anti-CD11c Fab', we generated anti-OVA titres greater than those produced by a 100-fold higher dose of OVA in complete Freund's adjuvant at day 28. These anti-OVA antibody titres were sustained and could be boosted further with targeted OVA on day 21. Investigations to explain this vaccine potency showed that, in addition to targeting splenic DC, anti-CDl1c antibodies delivered a powerful adjuvant effect and could boost humoral immunity against OVA even when the OVA was targeted to other molecules on DC, such as major histocompatibility complex class II, CD11a and CD11b. However, interestingly, this adjuvant effect was lost if OVA was targeted to other cells such as B cells via CD21 or CD19. The adjuvant effect was mediated through a marked enhancement of both germinal centre and extrafollicular plasma cell formation in responding spleens. These results demonstrate that anti-CD11c monoclonal antibody can both target antigen and act as a powerful adjuvant for rapid and sustained antibody responses. They also point to an interesting role for CR4 on DC in triggering B cells during humoral immunity.
  Immunology 05/2010; 131(1):141-51. · 3.32 Impact Factor